High power Laser in carpal tunnel syndrome

Comparative Evaluation of High-power Laser versus Anti-Inflammatory Effects of Corticosteroid Injection on Symptoms and Function in Patients with Mild to Moderate Carpal Tunnel Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241228064194N1

Enrollment

Registered

2025-04-20

Start date

2025-05-05

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: Patients will receive six sessions of high-power laser therapy over three weeks, with a two-day interval between each session, each lasting five minutes, according

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years mild to moderate carpal tunnel syndrome (CTS) based on nerve conduction study (NCS) findings

Exclusion criteria

Exclusion criteria: Patients who have surgical indications, such as severe weakness, thenar muscle atrophy, or lack of response to treatment. Concurrent neurological disorders based on electromyography observations, such as polyneuropathy, ulnar neuropathy, proximal median neuropathy, plexopathy, mononeuritis multiplex, cervical radiculopathy. pregnancy infection malignancy patients who have received corticosteroid injections in the past six months. patients with a history of wrist surgery for CTS treatment, allergy to corticosteroids contraindications for corticosteroids

Design outcomes

Primary

Measure	Time frame
Boston Questionnaire Score. Timepoint: Before the intervention, 2 weeks, 1 month, and 3 months after the completion of the intervention. Method of measurement: Boston Questionnaire.;Patient Satisfaction level. Timepoint: Before the intervention, 2 weeks, 1 month, and 3 months after the completion of the intervention. Method of measurement: Patient Satisfaction Questionnaire.;Visual Analog Scale for pain and numbness score. Timepoint: Before the intervention, 2 weeks, 1 month, and 3 months after the completion of the intervention. Method of measurement: Visual Analog Scale for pain and numbness.;Median Nerve Conduction Study (NCS) Findings. Timepoint: Before the intervention and 3 months after the completion of the intervention. Method of measurement: Nerve Conduction Study (NCS) device.	—

Measure

Time frame

Boston Questionnaire Score. Timepoint: Before the intervention, 2 weeks, 1 month, and 3 months after the completion of the intervention. Method of measurement: Boston Questionnaire.;Patient Satisfaction level. Timepoint: Before the intervention, 2 weeks, 1 month, and 3 months after the completion of the intervention. Method of measurement: Patient Satisfaction Questionnaire.;Visual Analog Scale for pain and numbness score. Timepoint: Before the intervention, 2 weeks, 1 month, and 3 months after the completion of the intervention. Method of measurement: Visual Analog Scale for pain and numbness.;Median Nerve Conduction Study (NCS) Findings. Timepoint: Before the intervention and 3 months after the completion of the intervention. Method of measurement: Nerve Conduction Study (NCS) device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Khosravipour

Tehran University of Medical Sciences

khosravifahime35@gmail.com+98 21 6119 2291

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026